Literature DB >> 4006367

Effect of hypothermic cardiopulmonary bypass on nitroprusside metabolism.

R A Moore, E A Geller, J D Gallagher, D L Clark.   

Abstract

At a rectal temperature of 25 degrees C, six patients undergoing hypothermic cardiopulmonary bypass received intravenous infusions of sodium nitroprusside (SNP) at a rate of 7.3 +/- 1.7 micrograms/kg/min for 20 minutes. Total SNP dose per patient was 11.0 +/- 1.1 mg. Blood samples for serum cyanide (CN-), red blood cell cyanide (RBC CN-), and thiocyanate (SCN-) determinations were drawn immediately before SNP infusion. These determinations were repeated at the end of the infusion, at the start of rewarming, and at a rectal temperature greater than 34 degrees C and 1, 4 (five subjects), and 24 hours (three subjects) thereafter. Extracorporeal blood flow was held constant at 2.4 L/min/m2 and mean arterial pressure was maintained between 50 to 100 mm Hg with phenylephrine (3.62 +/- 0.75 mg) during SNP infusion and trimethaphan (37.8 +/- 15.6 mg) after the end of the infusion. There was a significant increase in RBC CN- after the SNP infusion that lasted until the subjects were rewarmed. One subject developed a peak RBC CN- level of 0.8 microgram/ml. Plasma CN- levels changed little throughout and SCN- levels were elevated only after rewarming. The nonenzymatic release of free CN- from SNP was not inhibited by hypothermia, while the enzymatic detoxification of CN- to SCN- may have been delayed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006367     DOI: 10.1038/clpt.1985.111

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  3 in total

1.  Effects of hemoglobin concentration and temperature on the in vitro release of cyanide from sodium nitroprusside.

Authors:  Shigemasa Ikeda; Patricia A Frank; John F Schweiss; Sharon M Homan
Journal:  J Anesth       Date:  1997-12       Impact factor: 2.078

Review 2.  Strategies for managing perioperative hypertension.

Authors:  Ronak G Desai; Muhammad Muntazar; Michael E Goldberg
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

Review 3.  Cardiopulmonary bypass and the pharmacokinetics of drugs. An update.

Authors:  W A Buylaert; L L Herregods; E P Mortier; M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1989-07       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.